NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/10/2025
Back to search
Official data from USPTO
MERIDIAN BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/11/2025
Trademark type
Combined
Nice classes
1, 5, 10
Filing date
05/03/2018
Registration date
10/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2025
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2018
First use in commerce
01/01/2018
Drawing code
3
Owner type
03
Owner location
Cincinnati, OH
Examiner
LEE,REBECCA ANN
Current location
Historical data usage
Mark description
The mark consists of the words "MERIDIAN BIOSCIENCE" in stylized font with an upside-down arc positioned between the two "I"s in the word "MERIDIAN".
Holders and representatives
Holders
Meridian Bioscience, Inc.
Representatives
J. Michael Hurst KEATING MUETHING & KLEKAMP PLL
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
diagnostic reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; biochemicalsmonoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; protein in raw material form for scientific and medical research; enzymes for scientific and research purposes
Class 5
diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents; clinical medical reagents; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; enzyme preparations for medical purposes
Class 10
medical diagnostic machinesimmunoassay readers used to detect and measure antigens and antibodies; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for detecting gastrointestinal diseasesviral diseasesurinary diseasesrespiratory diseasesinfectious diseases
Publications
History of USPTO decisions and trademark events.
28 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2025
E815
TEAS SECTION 8 & 15 RECEIVED
04/30/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/24/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/23/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/20/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/20/2019
IUAF
USE AMENDMENT FILED
08/27/2019
EISU
TEAS STATEMENT OF USE RECEIVED
08/27/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/09/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2019
ALIE
ASSIGNED TO LIE
01/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/04/2018
GNRT
NON-FINAL ACTION E-MAILED
06/04/2018
CNRT
NON-FINAL ACTION WRITTEN
06/04/2018
DOCK
ASSIGNED TO EXAMINER
05/29/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/15/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2018
NWAP
NEW APPLICATION ENTERED
05/07/2018
Continuous trademark protection
Get notified about every new filing that threatens MERIDIAN BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.